Kininogen Antibody (288424) [Alexa Fluor® 350]

• Reactivity: Mu
• Applications: WB, IP
• Clone: 288424
• Clonality: Monoclonal
• Host: Rat
• Conjugate: Alexa Fluor 350

Kininogen Antibody (288424) [Alexa Fluor® 350] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse Kininogen
  Glu21-Ser661
  Accession # O08677
• Specificity: Detects mouse Kininogen Light Chain in direct ELISAs and Western blots. In Western blots, reacts with full length Kininogen (aa 21‑661) and several forms of the light chain starting at residue 389, and does not react with the heavy chain. In Western
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Rat
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Immunoprecipitation
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Kininogen Antibody (288424) [Alexa Fluor® 350]

• alpha 2-thiol Proteinase Inhibitor
• BDK
• BDK;BK;HAE6;HK;HMWK;Kininogen-1;KNG;KNG1
• Kininogen
• KNG1

Background

Kininogen, also known as alpha 2-thiol proteinase inhibitor, is a multi-function protein. There are two alternatively spliced forms, designated as the high molecular weight (HMW) and low MW (LMW) forms (1). The mouse HMW form is synthesized as a 661 amino acid (aa) precursor with a signal peptide (aa 1‑20). The mature chain (aa 21‑661) is further processed into the heavy (aa 21‑379) and the light (aa 389‑661) chains. The active peptide bradykinin (aa 380‑388) is released which has a variety of functions including muscle contraction, hypotension and inflammation. The heavy chain consists of three cystatin-like domains which are responsible for inhibiting cysteine proteases. The light chain consists of a His‑rich domain which is associated with the clotting activity. In comparison to the HMW form, the LMW Kininogen (432 residues) has the same sequence in its heavy chain and bradykinin but has a different sequence in its light chain (aa 401‑432). The LMW form is not involved in blood clotting.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.